Cytek Biosciences/$CTKB
13:30
09:10
04:45
00:25
20:00
1D1W1MYTD1Y5YMAX
About Cytek Biosciences
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of research and clinical tools with its novel technical approach of leveraging the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its patented FSP technology optimizes sensitivity and accuracy through its optical and electronic designs that utilize an inventive method of light detection and distribution to a specifically selected number and type of detectors. Its FSP cell analyzers, the Cytek Aurora, Northern Lights, and Cytek Aurora Evo systems, deliver high-resolution, high-content and high-sensitivity cell analysis and address the inherent limitations of other technologies.
Ticker
$CTKB
Sector
Primary listing
Employees
678
Headquarters
Website
CTKB Metrics
BasicAdvanced
$532m
-
-$0.58
1.23
-
Price and volume
Market cap
$532m
Beta
1.23
52-week high
$6.18
52-week low
$2.46
Average daily volume
894k
Financial strength
Current ratio
4.687
Quick ratio
3.938
Long term debt to equity
4.22
Total debt to equity
8.388
Interest coverage (TTM)
-98.59%
Profitability
EBITDA (TTM)
-36.303
Gross margin (TTM)
51.70%
Net profit margin (TTM)
-36.25%
Operating margin (TTM)
-21.49%
Effective tax rate (TTM)
-105.86%
Revenue per employee (TTM)
$300,000
Management effectiveness
Return on assets (TTM)
-5.89%
Return on equity (TTM)
-20.93%
Valuation
Price to revenue (TTM)
2.58
Price to book
1.62
Price to tangible book (TTM)
1.8
Price to free cash flow (TTM)
-41.029
Free cash flow yield (TTM)
-2.44%
Free cash flow per share (TTM)
-0.1
Growth
Revenue change (TTM)
3.61%
Earnings per share change (TTM)
553.82%
3-year revenue growth (CAGR)
7.13%
3-year earnings per share growth (CAGR)
219.78%
What the Analysts think about CTKB
Analyst ratings (Buy, Hold, Sell) for Cytek Biosciences stock.
CTKB Financial Performance
Revenues and expenses
CTKB Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs